These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 2989504

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PF, Laduron PM.
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [Abstract] [Full Text] [Related]

  • 5. Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors.
    Conn PJ, Sanders-Bush E.
    J Pharmacol Exp Ther; 1987 Aug; 242(2):552-7. PubMed ID: 3039120
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT-2 binding site.
    Conn PJ, Sanders-Bush E.
    J Neurosci; 1986 Dec; 6(12):3669-75. PubMed ID: 3025382
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serotonin-2 receptors coupled to phosphoinositide hydrolysis in a clonal cell line.
    Ivins KJ, Molinoff PB.
    Mol Pharmacol; 1990 May; 37(5):622-30. PubMed ID: 2160057
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus.
    Sanders-Bush E, Breeding M.
    J Pharmacol Exp Ther; 1988 Oct; 247(1):169-73. PubMed ID: 3139864
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site.
    Marcusson JO, Bäckström IT, Ross SB.
    Mol Pharmacol; 1986 Aug; 30(2):121-8. PubMed ID: 3016498
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J, Schohe-Loop R, Heine HG, Greuel JM, Mauler F, Schmidt B, Sommermeyer H, Glaser T.
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [Abstract] [Full Text] [Related]

  • 20. Allosteric modulation of 5-HT(1A) receptors by zinc: Binding studies.
    Barrondo S, Sallés J.
    Neuropharmacology; 2009 Feb; 56(2):455-62. PubMed ID: 18951909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.